Scherbaum W A, Seissler J
Department of Internal Medicine III, University of Leipzig, Germany.
Exp Clin Endocrinol Diabetes. 1995;103 Suppl 2:88-94. doi: 10.1055/s-0029-1211401.
Insulin-dependent diabetes mellitus (IDDM) is the consequence of a chronic process leading to the destruction of insulin producing beta cells of the pancreatic islets. Although the etiology of the disease is as yet unclear, the genetic background, environmental factors and the immune system are known to be the key factors contributing to the induction of the autoimmune process. The precipitating events leading to IDDM are largely unknown. In recent years research on the pathogenesis of IDDM has identified an array of pancreatic islet autoantigens which are recognized by the immune system. The islet cell autoantigens are principally recognized by autoreactive lymphocytes and autoantibodies present in the blood of the patients. Islet specific lymphocytes are thought to directly cause the disease while the antibodies have been used as valuable markers of IDDM and its preclinical phase. In this review we shall focus on cellular and humoral immunity to islet cell antigens which have been suggested to play a major role in the pathogenesis of IDDM and are useful tools for the prediction of the disease.
胰岛素依赖型糖尿病(IDDM)是一个导致胰岛中产生胰岛素的β细胞被破坏的慢性过程的结果。尽管该疾病的病因尚不清楚,但已知遗传背景、环境因素和免疫系统是促成自身免疫过程诱导的关键因素。导致IDDM的诱发事件在很大程度上尚不清楚。近年来,对IDDM发病机制的研究已经确定了一系列胰岛自身抗原,这些抗原可被免疫系统识别。胰岛细胞自身抗原主要被患者血液中存在的自身反应性淋巴细胞和自身抗体识别。胰岛特异性淋巴细胞被认为直接导致疾病,而抗体已被用作IDDM及其临床前期的重要标志物。在这篇综述中,我们将重点关注对胰岛细胞抗原的细胞免疫和体液免疫,这些免疫在IDDM的发病机制中被认为起主要作用,并且是预测该疾病的有用工具。